AVENIO ctDNA Surveillance Kit – Longitudinal Tumor Burden Monitoring

Material Number: N/A

Next-generation sequencing (NGS) liquid biopsy assay specially designed to monitor tumor burden in lung and colorectal cancer over time, as well as to assess for minimal residual disease (MRD). Contains 471 frequently mutated regions associated with the presence of disease across 197 genes.

Technical Datasheet: Technical datasheet


Roche AVENIO ctDNA Surveillance Kit for longitudinal tumor burden monitoring is a NGS liquid biopsy tumor profiling assay used to identify genomic aberrations in solid tumors.